# Satellos Bioscience Inc.: financial statements, quarterly

MSLE · Nasdaq · CIK 1421642 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/msle.md) · [Financials](/companies/msle/financials.md) · [Filings](/companies/msle/filings.md) · [Insiders](/companies/msle/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/msle/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.7](/filings/0001104659-26-035729.md) | [40.1](/filings/0001104659-26-035729.md) | [9.8](/filings/0001104659-26-035729.md) |
| Current assets | $m | [30.5](/filings/0001104659-26-035729.md) | [50.7](/filings/0001104659-26-035729.md) | [31.9](/filings/0001104659-26-035729.md) |
| Total assets | $m | [33.5](/filings/0001104659-26-035729.md) | [50.7](/filings/0001104659-26-035729.md) | [31.9](/filings/0001104659-26-035729.md) |
| Current liabilities | $m | [2.7](/filings/0001104659-26-035729.md) | [3.6](/filings/0001104659-26-035729.md) | [4.1](/filings/0001104659-26-035729.md) |
| Total liabilities | $m | [2.7](/filings/0001104659-26-035729.md) | [3.6](/filings/0001104659-26-035729.md) | [4.1](/filings/0001104659-26-035729.md) |
| Shareholders' equity | $m | [30.8](/filings/0001104659-26-035729.md) | [47.2](/filings/0001104659-26-035729.md) | [27.8](/filings/0001104659-26-035729.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 15,458,903 at 2025-12-31, from the cover of the [40-F filed 2026-03-27](/filings/0001104659-26-035729.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.